For: | Vogl TJ, Nour-Eldin NE, Emad-Eldin S, Naguib NN, Trojan J, Ackermann H, Abdelaziz O. Portal vein thrombosis and arterioportal shunts: Effects on tumor response after chemoembolization of hepatocellular carcinoma. World J Gastroenterol 2011; 17(10): 1267-1275 [PMID: 21455325 DOI: 10.3748/wjg.v17.i10.1267] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i10/1267.htm |
Number | Citing Articles |
1 |
Xiao-Hui Zhao, Hang Yuan, Wei-Li Xia, Li-Lin Zhang, Zhen Li, Guang-Shao Cao, Hai-Liang Li, Wei-Jun Fan, Hong-Le Li, Chen-Yang Guo, Quan-Jun Yao, Wen-Bo Zhu, Hong-Tao Hu. Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.977462
|
2 |
Li Zhou, Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu. Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2013; 12(1): 68 doi: 10.1016/S1499-3872(13)60008-9
|
3 |
Mary K. Bryant, David P. Dorn, Jessica Zarzour, J. Kevin Smith, David T. Redden, Souheil Saddekni, Ahmed Kamel Abdel Aal, Stephen H. Gray, Devin E. Eckhoff, Derek A. DuBay. Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization. HPB 2014; 16(4): 327 doi: 10.1111/hpb.12149
|
4 |
Daisuke Yasui, Satoru Murata, Tatsuo Ueda, Fumie Sugihara, Shiro Onozawa, Chiaki Kawamoto, Shinichiro Kumita. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study. Acta Radiologica 2018; 59(3): 266 doi: 10.1177/0284185117717762
|
5 |
Junwei Chen, Lisha Lai, Churen Zhou, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00581-8
|
6 |
|
7 |
Yusuke Imai, Masashi Hirooka, Yohei Koizumi, Yoshiko Nakamura, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Eiji Takeshita, Masanori Abe, Hiroaki Tanaka, Mie Kurata, Sohei Kitazawa, Yoichi Hiasa. Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma. Radiology Case Reports 2017; 12(1): 179 doi: 10.1016/j.radcr.2016.11.006
|
8 |
Wei-Li Xia, Xiao-Hui Zhao, Yuan Guo, Hong-Tao Hu, Hai-Liang Li. TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts. Journal of Hepatocellular Carcinoma 2024; : 1689 doi: 10.2147/JHC.S480082
|
9 |
Yuki Nakajima, Atsushi Takahashi, Yukiko Kanno, Naohiko Gunji, Hiromichi Imaizumi, Manabu Hayashi, Ken Okai, Kazumichi Abe, Hiroshi Watanabe, Hiromasa Ohira. Paralytic Ileus due to Superior Mesenteric Venous Thrombosis after Transarterial Injection for Hepatocellular Carcinoma. Internal Medicine 2016; 55(1): 37 doi: 10.2169/internalmedicine.55.5907
|
10 |
Thierry de Baere, Yasuaki Arai, Riccardo Lencioni, Jean-Francois Geschwind, William Rilling, Riad Salem, Osamu Matsui, Michael C. Soulen. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. CardioVascular and Interventional Radiology 2016; 39(3): 334 doi: 10.1007/s00270-015-1208-y
|
11 |
Ja Kyung Kim, Jun Won Kim, Ik Jae Lee, Seung-Moon Joo, Kwang-Hun Lee, Eun-Suk Cho, Jeong-Sik Yu, Tae Joo Jeon, Yonsoo Kim, Jung Il Lee, Kwan Sik Lee. Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study. Radiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0873-1
|
12 |
Thomas J. Vogl, Patrik Schaefer, Thomas Lehnert, Nour-Eldin A. Nour-Eldin, Hanns Ackermann, Emmanuel Mbalisike, Renate Hammerstingl, Katrin Eichler, Stephan Zangos, Nagy N. N. Naguib. Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE). European Radiology 2016; 26(3): 755 doi: 10.1007/s00330-015-3869-y
|
13 |
Pin-Ko Chen, Sung-Hua Chiu, Ming-Ting Tsai, Kai-Hsiang Chang, Wei-Chou Chang, Hsuan-Hwai Lin, Cheng-Hsiang Lo, Guo-Shu Huang, Ping-Ying Chang. Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shunt. Journal of the Chinese Medical Association 2022; 85(4): 491 doi: 10.1097/JCMA.0000000000000696
|
14 |
Ji-Won Kang, Jin Hyoung Kim, Gi-Young Ko, Dong Il Gwon, Hyun-Ki Yoon, Kyu-Bo Sung. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt. Acta Radiologica 2012; 53(5): 545 doi: 10.1258/ar.2012.110476
|
15 |
L. Xiao, Q. Liu, W. Zhao, H. Pang, Q. Zeng, Y. Chen, J. Zhao, Q. Mei, X. He. Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumour thrombosis and arterioportal shunts: efficacy and prognostic factors. Clinical Radiology 2018; 73(12): 1056.e17 doi: 10.1016/j.crad.2018.08.002
|
16 |
Lindsay M. Thornton, Brian S. Geller, Eric W. Pepin, Jehan L. Shah, Melissa Kapp, Beau B. Toskich. Safety of Radioembolization in the Setting of Angiographically Apparent Arterioportal Shunting. Journal of Vascular and Interventional Radiology 2018; 29(11): 1511 doi: 10.1016/j.jvir.2018.06.012
|
17 |
Thomas Helmberger. Liver Radioembolization with 90Y Microspheres. Medical Radiology 2013; : 119 doi: 10.1007/174_2013_821
|
18 |
Ninggang Zheng, Xiaodong Wei, Dongzhi Zhang, Wenxiao Chai, Ming Che, Jiangye Wang, Binbin Du. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus. Medicine 2016; 95(26): e3959 doi: 10.1097/MD.0000000000003959
|
19 |
Junwei Chen, Lisha Lai, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10361-5
|
20 |
F. Cauchy, D. Fuks, J. Belghiti. HCC: current surgical treatment concepts. Langenbeck's Archives of Surgery 2012; 397(5): 681 doi: 10.1007/s00423-012-0911-2
|
21 |
Yuo-Chen Kuo, Maureen P. Kohi, David M. Naeger, Ricky T. Tong, K. Pallav Kolli, Andrew G. Taylor, Jeanne M. Laberge, Robert K. Kerlan, Nicholas Fidelman. Efficacy of TACE in TIPS Patients: Comparison of Treatment Response to Chemoembolization for Hepatocellular Carcinoma in Patients With and Without a Transjugular Intrahepatic Portosystemic Shunt. CardioVascular and Interventional Radiology 2013; 36(5): 1336 doi: 10.1007/s00270-013-0698-8
|
22 |
Ahmed Mostafa Mohamed, Mohamed El Gharib A. Elmaaty, Ayman Mohamed Ibrahim, Waleed Hamed, Amr Hafez El Fouly. Diagnosis of arterioportal shunts in cases of hepatocellular carcinoma using multidetector CT: Impact on clinical management. The Egyptian Journal of Radiology and Nuclear Medicine 2014; 45(1): 25 doi: 10.1016/j.ejrnm.2013.09.011
|
23 |
Thomas J. Vogl, Katrin Eichler, Stephan Zangos. Regionale Therapie maligner Tumoren. 2013; : 237 doi: 10.1007/978-3-642-35014-6_19
|
24 |
Michael C. Soulen, Thierry de Baere. Image-Guided Interventions in Oncology. 2020; : 29 doi: 10.1007/978-3-030-48767-6_3
|
25 |
|